의료기기 커넥티비티 시장 : 기기 유형, 접속 기술, 최종 사용자, 용도별 - 세계 예측(2026-2032년)

The Medical Device Connectivity Market was valued at USD 4.81 billion in 2025 and is projected to grow to USD 5.79 billion in 2026, with a CAGR of 20.62%, reaching USD 17.89 billion by 2032.

Medical device connectivity has evolved from a niche engineering concern into a foundational capability for modern care delivery. Across hospitals, ambulatory centers, and home settings, connected devices enable continuous monitoring, streamline clinical workflows, and surface data that clinicians and administrators use to make faster, more informed decisions. This introduction frames the essential technical and organizational dimensions that stakeholders must address to realize reliable, secure, and clinically meaningful connectivity.

Transitioning from siloed point solutions to an integrated ecosystem requires attention to interoperability frameworks, device lifecycle management, cybersecurity resilience, and the human factors that affect clinician adoption. Moreover, the proliferation of wireless modalities and edge processing is changing how data are transported, aggregated, and contextualized, with implications for network architecture and device certification. In short, success depends on aligning clinical objectives with technical design choices and procurement strategies.

Finally, the introduction underscores the necessity of cross-functional collaboration among clinical leaders, IT architects, procurement, and external vendors. By establishing governance, accountability, and clear performance metrics early in the planning cycle, organizations can reduce implementation friction, improve uptime, and accelerate the path from connectivity pilots to sustained clinical value.

How technological and regulatory change including edge computing, AI analytics, software-defined devices, and stricter privacy regimes are redefining connectivity

The landscape for medical device connectivity is undergoing multiple, concurrent transformations that are reshaping design priorities and operational models. Advances in edge computing and on-device analytics are enabling more localized decision support and reducing latency, which improves responsiveness for critical monitoring and therapeutic systems. At the same time, evolving wireless standards and low-power wide-area technologies are expanding the range of devices that can reliably transmit clinical information outside traditional care settings.

Regulatory and privacy regimes are adjusting to new risk profiles introduced by software-defined functionality and continuous data flows. This in turn is driving tighter security requirements, mandatory reporting for cyber incidents, and explicit obligations for software maintenance and patching. Meanwhile, commercial dynamics are changing as device manufacturers adopt platform strategies and software monetization models, creating a new interplay between hardware life cycles and subscription-based software support.

Taken together, these shifts demand that health systems and vendors rethink procurement, integration, and support. Implementation roadmaps must now incorporate continuous monitoring of device performance, proactive cybersecurity practices, and a stronger emphasis on interoperability testing. As a result, organizations that can integrate technical, clinical, and commercial perspectives will be best positioned to capture the efficiency and quality gains that connectivity promises.

Cumulative impact of 2025 US tariffs on medical device connectivity driving supplier diversification, sourcing shifts, manufacturing decisions, and procurement adaptations

Recent tariff changes and trade policy adjustments in the United States in 2025 have introduced material operational considerations for stakeholders in the medical device connectivity ecosystem. Tariffs affecting electronic components, communications modules, and certain assembly services can increase procurement costs, prompting organizations to re-evaluate supplier selection, inventory policies, and contractual terms. In response, many manufacturers and integrators are accelerating supplier diversification and seeking alternative sourcing strategies to reduce exposure to single-country supply concentration.

In addition, the cumulative effect of tariffs can influence decisions about where to locate manufacturing and final assembly operations, particularly for devices with complex radio subsystems or custom firmware. As firms consider nearshoring or onshoring options, they must weigh capital expenditure, labor skill availability, and regulatory compliance implications against the potential benefits of shorter lead times and improved supply chain resilience. Procurement teams, therefore, are recalibrating total cost of ownership models to include tariff risk and longer-term supply stability metrics.

From a strategic perspective, tariffs can prompt stronger collaboration between clinicians, supply chain leaders, and product teams to prioritize modularity and replaceable components that are less sensitive to tariff categories. Transitional measures include renegotiating supplier agreements, securing longer-term component commitments, and investing in certification and verification processes that enable quicker qualification of substitute parts without disrupting clinical operations.

Segmentation insights comparing device types, wired and wireless connectivity variants, end-user deployment environments, and application integration priorities

Meaningful insights emerge when device connectivity is examined through practical segmentation lenses that mirror procurement and integration decisions. Based on device type, connectivity considerations differ markedly between imaging devices, infusion pumps, laboratory diagnostics, patient monitoring devices, and surgical devices; imaging systems often require high-bandwidth, low-latency links and integration with enterprise PACS and VNA platforms, while infusion pumps and bedside monitors prioritize deterministic reliability and secure telemetry for medication and vital-sign data. In parallel, connectivity technology choices impose distinct engineering and operational trade-offs. Wired implementations leveraging Ethernet, RS232, or USB provide predictable latency and power options for many bedside and fixed assets, whereas wireless modalities such as Bluetooth, cellular, Wi-Fi, and ZigBee enable mobility, remote monitoring, and field deployment but require ongoing spectrum management and security controls.

End-user context shapes deployment complexity and support models. Ambulatory care centers, home healthcare environments, hospitals, and telemedicine providers each present different network topologies, staffing capabilities, and physical constraints that affect device onboarding, monitoring, and maintenance. Finally, application-level segmentation-spanning device management, patient monitoring, telemedicine, and workflow management-determines integration depth with EHRs, middleware platforms, and analytics engines. Device management demands robust firmware update paths and inventory controls, patient monitoring emphasizes continuous data fidelity and alarm reliability, telemedicine stresses upstream bandwidth and privacy safeguards, and workflow management requires seamless handoffs between devices and clinical systems. When these segmentation perspectives are considered together, they guide architecture choices, testing priorities, and commercialization strategies that reflect real-world operational requirements.

Comparative regional intelligence on medical device connectivity: how policy, infrastructure, and clinical adoption vary across Americas, EMEA, and Asia-Pacific

Regional dynamics play a central role in shaping both the adoption cadence and the technical design of connected medical devices. In the Americas, procurement often emphasizes cost-effectiveness, rapid deployment, and integration with large acute networks, while payers and health systems increasingly demand demonstrable clinical and economic outcomes tied to connectivity investments. Europe, Middle East & Africa combines a heterogeneous set of regulatory regimes and infrastructure maturity levels; stricter data protection rules in many European jurisdictions increase the emphasis on privacy-by-design, whereas certain markets in EMEA prioritize ruggedized and low-power solutions for distributed care settings.

Asia-Pacific presents a spectrum of adoption scenarios that range from highly advanced urban systems with sophisticated wireless infrastructures to emerging markets where affordability and interoperability with national health programs are paramount. Across these regions, infrastructure readiness for wireless technologies, the availability of certified local suppliers, and the regional approach to approval and post-market surveillance inform both vendor go-to-market strategies and health system procurement roadmaps. Consequently, companies and healthcare organizations must align regional commercialization plans with local regulatory expectations, network performance characteristics, and clinical workflows to ensure that connectivity implementations deliver consistent clinical value.

How companies prioritize partnerships, software and security investments, supply diversification, and commercial approaches for device connectivity

Corporate behavior in the connectivity landscape reveals several persistent themes. Leading manufacturers and platform vendors are prioritizing partnerships to assemble end-to-end solutions that combine device hardware, connectivity modules, and secure cloud services. Investment flows increasingly favor software and security capabilities as manufacturers shift toward platform-based offerings and lifecycle revenue models tied to updates, analytics, and managed services. At the same time, suppliers are pursuing supply chain diversification and localized manufacturing relationships to mitigate geopolitical and tariff-related risk while maintaining continuity for critical clinical devices.

From an execution standpoint, companies are standardizing on a smaller number of connectivity stacks and certification pathways to reduce integration overhead for hospital IT teams. They are also investing in developer toolchains and SDKs that accelerate clinical integrations, and in professional services to support implementation at scale. Strategic M&A and partnership activity tends to focus on complementary capabilities such as cybersecurity firms, cloud-native analytics providers, and middleware specialists. These moves reflect a broader logic: firms that can offer secured, validated integration paths and clear total-cost-of-support propositions become preferable partners for health systems that seek to reduce complexity and accelerate time-to-value.

Recommendation blueprint for leaders to secure interoperable medical device connectivity, mitigate risk, optimize costs, and accelerate clinical adoption

Industry leaders should adopt a pragmatic set of actions to accelerate secure and effective device connectivity. First, establish a cross-functional governance model that unites clinical, procurement, IT, and cybersecurity stakeholders and defines success metrics tied to clinical outcomes and operational reliability. Second, prioritize interoperability testing and certification early in procurement cycles to avoid costly rework and to reduce time-to-integration with electronic health records and middleware platforms. Third, adopt a risk-based security posture that combines device-level hardening, network segmentation, and continuous monitoring to detect and remediate threats without introducing untenable maintenance burdens.

Additionally, organizations should build supplier evaluation criteria that include supplier resilience against tariff and supply-chain shocks, the availability of local support, and software lifecycle commitments. Investing in staff training and change management will improve clinician adoption and reduce alarm fatigue, while phased rollouts and pilot programs can validate technical assumptions and surface operational constraints. Finally, leaders should consider commercial frameworks that share responsibility for long-term support and updates, such as managed service agreements or joint-risk contracts, so that vendors and providers jointly optimize for uptime, security, and clinical effectiveness.

Methodology overview of mixed methods, stakeholder interviews, data triangulation, and validation used to assess medical device connectivity trends

This research employed a mixed-methods approach combining qualitative insights from stakeholder interviews with systematic secondary research and structured data reconciliation. Primary engagements included conversations with clinical leaders, device engineers, IT architects, and procurement professionals to surface implementation challenges, adoption drivers, and supplier selection criteria. These interviews were used to validate thematic findings, identify real-world constraints, and collect representative use cases that informed the analysis.

Secondary work included review of public regulatory guidance, standards roadmaps, and vendor technical documentation to construct a taxonomy of connectivity modalities, security requirements, and interoperability frameworks. Data triangulation techniques were applied to reconcile different evidence streams and to ensure that conclusions reflect convergence across sources. Validation protocols included peer review by independent domain experts and iterative revisions to incorporate feedback from practitioner interviews. Together, these methods produced a structured, transparent assessment suitable for informing procurement strategies, product roadmaps, and implementation planning.

Final perspective on priorities and enablers to achieve secure, interoperable medical device connectivity across clinical and home care settings

The analysis synthesizes strategic priorities, operational constraints, and technological trajectories that will determine the pace and quality of medical device connectivity adoption. Secure interoperability, pragmatic lifecycle management, and resilient supply chains are the recurring priorities for organizations that aim to translate connectivity into measurable clinical and operational benefits. Additionally, the interplay between device firmware, middleware platforms, and clinical workflows highlights the importance of integrated testing and vendor accountability to minimize integration friction and sustain long-term performance.

Looking ahead, the organizations that balance technical rigor with pragmatic deployment strategies-such as modular architectures, phased rollouts, and shared support arrangements-will achieve more consistent outcomes. Equally important is the need for continuous governance and clinician engagement to ensure that connected systems evolve in step with clinical protocols and regulatory expectations. In sum, realizing the promise of medical device connectivity requires coordinated action across technology, clinical practice, and commercial frameworks to deliver scalable and secure solutions across care settings.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Device Connectivity Market, by Device Type

• 8.1. Imaging Devices
• 8.2. Infusion Pumps
• 8.3. Laboratory Diagnostics
• 8.4. Patient Monitoring Devices
• 8.5. Surgical Devices

9. Medical Device Connectivity Market, by Connectivity Technology

• 9.1. Wired
  • 9.1.1. Ethernet
  • 9.1.2. RS232
  • 9.1.3. USB
• 9.2. Wireless
  • 9.2.1. Bluetooth
  • 9.2.2. Cellular
  • 9.2.3. Wi-Fi
  • 9.2.4. ZigBee

10. Medical Device Connectivity Market, by End User

• 10.1. Ambulatory Care Centers
• 10.2. Home Healthcare
• 10.3. Hospitals
• 10.4. Telemedicine Providers

11. Medical Device Connectivity Market, by Application

• 11.1. Device Management
• 11.2. Patient Monitoring
• 11.3. Telemedicine
• 11.4. Workflow Management

12. Medical Device Connectivity Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Medical Device Connectivity Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Medical Device Connectivity Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. United States Medical Device Connectivity Market

16. China Medical Device Connectivity Market

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025
• 17.5. Ascom Holding AG
• 17.6. Baxter International Inc.
• 17.7. Becton, Dickinson and Company
• 17.8. Cisco Systems, Inc.
• 17.9. Digi International Inc.
• 17.10. Dragerwerk AG & Co. KGaA
• 17.11. GE HealthCare Technologies Inc.
• 17.12. Honeywell International Inc.
• 17.13. ICU Medical, Inc.
• 17.14. Koninklijke Philips N.V.
• 17.15. Lantronix, Inc.
• 17.16. Masimo Corporation
• 17.17. Medtronic plc
• 17.18. Mindray Medical International Limited
• 17.19. NantHealth, Inc.
• 17.20. Nihon Kohden Corporation
• 17.21. Oracle Corporation
• 17.22. S3 Connected Health
• 17.23. Siemens Healthineers AG
• 17.24. Stryker Corporation